Women’s choices and outcomes with injectable and oral HIV prevention in Malawi
Better Info on Women's PrEP Choices and Outcomes in Malawi
This project follows women in Malawi offered long-acting injectable PrEP or daily oral PrEP to learn which options they prefer, how often they switch, and how long they continue protection.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11394649 on NIH RePORTER |
What this research studies
You would be followed as clinics in Malawi roll out injectable PrEP alongside oral PrEP through an existing program called PathToScale. The study will use clinic records, surveys, and targeted follow-up (including tracing people who stop PrEP) to track patterns of use over time. Researchers will ask about reasons for choosing, switching, or stopping products and record related health outcomes. The focus is on capturing real-world experiences during the early expansion of these prevention options.
Who could benefit from this research
Good fit: Women in Malawi who are eligible for HIV prevention and who are offered oral or injectable PrEP at participating clinics in the PathToScale rollout.
Not a fit: People outside the participating Malawi clinics, men, or women not offered PrEP through the rollout would not directly benefit from taking part.
Why it matters
Potential benefit: If successful, the findings could help clinics provide better information and support so more women can choose and stay on the HIV prevention option that fits them.
How similar studies have performed: Clinical trials have shown long-acting injectable PrEP to be highly effective, but large-scale real-world studies of women's choices and continuation in routine programs are limited.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Schwartz, Sheree Renae — Johns Hopkins University
- Study coordinator: Schwartz, Sheree Renae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.